Sign Up Now
Get instant access to over 1 million+ study documents
OR
Already registered? click here to login
By creating your account, you agree to our terms of service, privacy policy and student honor code.
The threat of reprisal is the most effective measure against intellectual property right infringements, and for this reason one of the most essential actions that can be taken in this regard -- and frequently is -- is the filing of civil and criminal charges against companies that infringe upon these rights in an aggressive and uncompromising manner (Long 2000). This not only limits damages, but dissuades future infringement.
Protecting Other Firms
Refraining from infringing on another company's tangible and intellectual property rights might be seem to be a simple task, but it does require that certain actions are taken by pharmaceutical company managers. First and foremost, knowledge of the property right laws in effect must be obtained and thoroughly understood in order to refrain from infringing upon them. With this knowledge in place, managers can ensure that any similarities that develop between their own products and/or processes will not be legally infringing upon another company's rights. In order for this to be fully effective, however, companies must ironically have some knowledge of current patents and property rights obtained by other companies in the industry, especially those developing similar products.
This is the reason, of course, that certain patent information is made publicly available, and managers must take careful consideration of these records when guiding their companies through development...
The careful attention of the manager to industry and company-specific developments will also ensure that any attempts at infringement by research and production leaders and/or staff can be detected early and quickly dealt with, rather than becoming an unexpected embarrassment for the company after a great deal of capital has been spent on development.
References
Ghauri, P. & Rao, P. (2008). "Intellectual property, pharmaceutical MNEs and the developing world." Accessed 17 January 2010. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6W5M-4SY6YJR-3&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_searchStrId=1171065541&_rerunOrigin=google&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=e667e8f8848aae7fd6fe1c222ed046d6
GTN. (2004). "Intellectual property summary." Accessed 17 January 2010. http://www.cid.harvard.edu/cidtrade/issues/ipr.html
Kaufman, J. (2008). "Intellectual Property Rights and the Pharmaceutical Industry." Accessed 17 January 2010. http://www.america.gov/st/econ-english/2008/April/20080429230451myleen0.4181027.html
Long, C. (2000). "Intellectual property rights in emerging markets." Accessed 17 January 2010. http://www.scribd.com/doc/2011460/Intellectual-Property-Rights-in-Emerging-Markets
Threats to Ownership and Copyright of Intellectual Property The intellectual property (IP) is defined as an original creative work, which may be tangible or intangible form legally protected by law. (Raman, 2004). The intellectual properties include the rights to scientific, artistic and literary works. Moreover, IP covers the invention of human endeavor, scientific discoveries, and industrial design. A current revolution of information technology has made IPs the greatest assets of assets.
China's Intellectual Property Rights: Current Issues, Strategic Considerations And Problem Solving In this paper, the focus is primarily on the Intellectual Property Rights (IPR) that are given to individuals within the Republic of China. The paper starts off by defining IPR and the different ways that IPR is provided like copyright infringement. The paper them moves on to define IPR and its progression in China through the imperialistic years, the era
Pharmaceutical industries have to operate in an environment that is highly competitive and subject to a wide variety of internal and external constraints. In recent times, there has been an increasing trend to reduce the cost of operation while competing with other companies that manufacture products that treat similar afflictions and ailments. The complexities in drug research and development and regulations have created an industry that is subject to intense
Centralization Structure of the Model and its Operationalization The Model In the wake of a highly volatile economy, organizations must find ways to improve their bottom lines and profitability through new and innovative means. Many businesses realize that one of the most important assets that they possess is intellectual capital in the form of intellectual assets and human capital. As businesses struggle to revitalize their assets and assess their value, they are
In other words: Lead users are individuals who use a product that has a number of unknown needs and who also benefit if they find a solution to those needs. This is unique in that it takes a different approach to traditional market research -- instead of collecting information from users at the center of the target market, it collects information about both needs and solutions from the leading
In civilian life, such individuals will have gained a traditional ethical education whereas in a combat context, such individuals will have been instructed on the use of lethal force. According to Willis, "habit and practice help the willingness and capacity to kill on command. The new recruit or volunteer may, and likely has, the innate reservation against killing anyone. Yet day in and day out, the 'normal' person is